Barry O’Connor

Senior Director, Head of Biopharma Business Development, AMEA Guardant Health

Seminars

Wednesday 12th November 2025
Next-Generation Insights: Integrating Genomics & Epigenomics in Oncology Clinical Trials
4:25 pm
  • Epigenomics: The new frontier for biomarker discovery
  • Expand patient eligibility through combining genomic and epigenomic alterations
  • Methylation-enhanced liquid biopsy improves deletion calling
Barry O'Connor